Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases

Cardiovascular Diseases Clinical Trial

— AHS  

Official title:

Abuja Heart Study (AHS) is a Multi-site Prospective Epidemiological Investigation of Cardiovascular Disease (CVD) .

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00629954
• Other study ID #: HIFA-001
• Status: Recruiting
• Phase: N/A
• First received: February 25, 2008
• Last updated: September 25, 2013
• Start date: November 2009
• Est. completion date: November 2016

Study information

• Verified date: August 2012
• Source: Healthsystem Plus
• Contact: Uchenna N Onyeachom
• Email: uonyeachom[@]hvori.org
• Is FDA regulated: No
• Health authority: Nigeria: The National Health Research Ethics Committee
• Study type: Observational

Clinical Trial Summary

This is a multi-site prospective epidemiological investigation of cardiovascular disease (CVD) among Abuja residents from the rural and metropolitan area.

Description:

Sub-Saharan Africa continues to fight the battle of infectious diseases such as HIV/AIDS, Tuberculosis and Malaria. But given all the international efforts geared to curing and containing these diseases, and with progress made in various countries, Sub-Saharan Africa is now heading into another type of epidemic, cardiovascular disease (CVD). Predicted statistics have shown that cardiovascular diseases will become the leading cause of death in developing countries within the next 10 to 15 years, however relatively few population-based studies have examined CVD in Africa .

Although control of communicable ,childhood ,and maternal diseases has benefited from an international efforts on clinical care, policy and implementation,such large scale effort are lacking for CVD and have left both policymakers and individuals with decisions on health issues without adequate information.

Prior to the commencement of the study,series of community meetings and focus groups discussions will be held to identify ways to enhance participation. An extensive examination will include a series of questionnaires dealing with lifestyle habits, medical history, social and cultural factors, physical assessments which include height, weight,central blood pressure assessment of arterial stiffness and autonomic function and laboratory measurements for cholesterol, other lipids, glucose ,c-reactive protein among others.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: November 2016
• Est. primary completion date: November 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

• Some history of cardiovascular disease,PLWHA

• Patients have to agree to participate by signing a consent

• 18 years and older

Exclusion Criteria:

• Stroke

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cardiovascular Diseases
• High Blood Pressure
• Hypertension

Locations

Country	Name	City	State
Nigeria	National Hospital Abuja	Abuja	Federal Capital Territory
Nigeria	Nigerian Defense Medical Center	Abuja
Nigeria	State House Medical Center	Abuja	Federal Capital Territory
Nigeria	Bwari General Hospital	Bwari	Federal Capital Territory
Nigeria	Gwagwalada Specialist Hospital	Federal Capital Territory

Sponsors (5)

Lead Sponsor	Collaborator
Healthsystem Plus	Akaza Research, Byrne Healthcare, Federal Ministry of Health, Nigeria, Harvard Clinical Research Institute

Country where clinical trial is conducted

Nigeria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	determine the roles of sociocultural factors, such as poverty,gender, literacy, stress in the development of CVD and associated risk factors		5	No
Secondary	familial or hereditary factors		10	No